ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2592

Clinical Significance Of Endothelial Vasodilator Function Evaluated By Endopat In Patients With Systemic Sclerosis

Naohiko Aozasa1, Yoshihide Asano1, Masaru Hatano2, Ryosuke Saigusa1, Kouta Takakuwa1, Takehiro Takahashi1, Tetsuo Toyama1, Hayakazu Sumida1, Atsushi Yao3, Koichiro Kinugawa4, Hisataka Maki2, Toshiro Inaba2, Hironori Muraoka2, Shun Minatsuki2, Issei Komuro2 and Shinichi Sato1, 1Dermatology, University of Tokyo Graduate School of Medicine, Tokyo, Japan, 2Cardiovascular Medicine, University of Tokyo Graduate School of Medicine, Tokyo, Japan, 3Division for Health Service Promotion, University of Tokyo Graduate School of Medicine, Tokyo, Japan, 4Department of Therapeutic strategy for heart failure, University of Tokyo Graduate School of Medicine, Tokyo, Japan

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Pulmonary Involvement and systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Sclerosis, Fibrosing Syndromes, and Raynaud’s - Clinical Aspects and Therapeutics II

Session Type: Abstract Submissions (ACR)

Background/Purpose: Systemic sclerosis (SSc) is a multisystem autoimmune disease characterized by initial vascular injuries and resultant fibrosis of skin and certain internal organs. Evidence has shown that vascular impairment in SSc may be a sign of endothelial dysfunction. The peripheral arterial tonometry (EndoPAT) is a device that is used to assess endothelial vasodilator function in a rapid and non-invasive fashion. Since its clinical significance has not been well established in SSc, we evaluated the association between the values of reactive hyperemia measured by EndoPAT and clinical features of SSc.

Methods: Thirty-three consecutive patients with SSc were studied, including 15 patients with limited cutaneous SSc (lcSSc) and 18 with diffuse cutaneous SSc (dcSSc). Clinical symptoms, such as swollen fingers, nailfold bleeding (NFB), pitting scars, digital ulcers, and Raynaud’s phenomenon, were meticulously recorded. Reactive hyperemia peripheral arterial tonometry index (RHI) was measured using EndoPAT on all patients. Mean pulmonary artery pressure (mPAP) was measured by right heart catheterization. Correlations of RHI with various clinical symptoms, disease duration, laboratory data and disease subtypes were examined.

Results: RHI values were inversely correlated with mPAP (r = -0.47, p < 0.01), while positively correlated with %DLco (r = 0.35, p < 0.05). Furthermore, the values of RHI inversely correlated with disease duration in dcSSc patients (r = -0.45, p < 0.05), but not in lcSSc patients. Of note, RHI values were increased after one month of oral prednisolone in 4 patients with progressive skin sclerosis in whom skin stiffness was improved in response to the treatment.

Conclusion: Although mPAPs of all the patients enrolled in this study were less than 25 mmHg, the values of RHI were significantly and inversely correlated with mPAP, suggesting that the decreased RHI value reflects the reduction of the pulmonary vascular bed prior to the development of definite pulmonary arterial hypertension in SSc. Since skin sclerosis may affect the values of RHI, we have to be cautious to interpret the impact of prednisolone on endothelial function evaluated by EndoPAT in this disease.


Disclosure:

N. Aozasa,
None;

Y. Asano,
None;

M. Hatano,
None;

R. Saigusa,
None;

K. Takakuwa,
None;

T. Takahashi,
None;

T. Toyama,
None;

H. Sumida,
None;

A. Yao,
None;

K. Kinugawa,
None;

H. Maki,
None;

T. Inaba,
None;

H. Muraoka,
None;

S. Minatsuki,
None;

I. Komuro,
None;

S. Sato,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clinical-significance-of-endothelial-vasodilator-function-evaluated-by-endopat-in-patients-with-systemic-sclerosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology